These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8702541)

  • 1. The major calpain isozymes are long-lived proteins. Design of an antisense strategy for calpain depletion in cultured cells.
    Zhang W; Lane RD; Mellgren RL
    J Biol Chem; 1996 Aug; 271(31):18825-30. PubMed ID: 8702541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth of human TE2 and C-33A cells by the cell-permeant calpain inhibitor benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone.
    Mellgren RL; Shaw E; Mericle MT
    Exp Cell Res; 1994 Nov; 215(1):164-71. PubMed ID: 7957664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain: a cytosolic proteinase active at the membranes.
    Molinari M; Carafoli E
    J Membr Biol; 1997 Mar; 156(1):1-8. PubMed ID: 9070458
    [No Abstract]   [Full Text] [Related]  

  • 4. Calpains and myogenesis.
    Cottin P; Poussard S; Dargelos E; Balcerzak D; Aragon B; Brustis JJ; Ducastaing A
    Methods Mol Biol; 2000; 144():173-80. PubMed ID: 10818762
    [No Abstract]   [Full Text] [Related]  

  • 5. [Calpain and calpastatin].
    Murachi T
    Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition.
    Zhang W; Lu Q; Xie ZJ; Mellgren RL
    Oncogene; 1997 Jan; 14(3):255-63. PubMed ID: 9018111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide.
    McCartney CE; Ye Q; Campbell RL; Davies PL
    J Biol Chem; 2018 Nov; 293(46):17716-17730. PubMed ID: 30254072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.
    Mellgren RL
    J Biol Chem; 1997 Nov; 272(47):29899-903. PubMed ID: 9368065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells.
    Lane RD; Allan DM; Mellgren RL
    Exp Cell Res; 1992 Nov; 203(1):5-16. PubMed ID: 1426051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of calpain (Ca(2+)-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts.
    Barnoy S; Zipser Y; Glaser T; Grimberg Y; Kosower NS
    J Cell Biochem; 1999 Sep; 74(4):522-31. PubMed ID: 10440922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a Chinese hamster ovary cell clone possessing decreased mu-calpain content and a reduced proliferative growth rate.
    Mellgren RL; Lu Q; Zhang W; Lakkis M; Shaw E; Mericle MT
    J Biol Chem; 1996 Jun; 271(26):15568-74. PubMed ID: 8663205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular regulatory system involving calpain and calpastatin.
    Murachi T
    Biochem Int; 1989 Feb; 18(2):263-94. PubMed ID: 2548504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct kinetics of subunit autolysis in mammalian m-calpain activation.
    Saido TC; Nagao S; Shiramine M; Tsukaguchi M; Yoshizawa T; Sorimachi H; Ito H; Tsuchiya T; Kawashima S; Suzuki K
    FEBS Lett; 1994 Jun; 346(2-3):263-7. PubMed ID: 8013644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunolocalization of the calpain-calpastatin system in the human oocyte.
    Ben-Aharon I; Ben-Yosef D; Amit A; Shalgi R
    Fertil Steril; 2005 Jun; 83(6):1807-13. PubMed ID: 15950654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E64d, a membrane-permeable cysteine protease inhibitor, attenuates the effects of parathyroid hormone on osteoblasts in vitro.
    Murray EJ; Grisanti MS; Bentley GV; Murray SS
    Metabolism; 1997 Sep; 46(9):1090-4. PubMed ID: 9284902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
    Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
    Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of calpain and calpastatin from rainbow trout, Oncorhynchus mykiss.
    Saito M; Li H; Thompson VF; Kunisaki N; Goll DE
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Apr; 146(4):445-55. PubMed ID: 17276714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpains and calpastatin in SH-SY5Y neuroblastoma cells during retinoic acid-induced differentiation and neurite outgrowth: comparison with the human brain calpain system.
    Grynspan F; Griffin WB; Mohan PS; Shea TB; Nixon RA
    J Neurosci Res; 1997 May; 48(3):181-91. PubMed ID: 9160241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase.
    Mellgren RL
    Biochem Biophys Res Commun; 1997 Jul; 236(3):555-8. PubMed ID: 9245687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.